Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
- DOI
- 10.1093/infdis/jiad293
- Published
- 2024 Feb 14
- Container
- The Journal of infectious diseases
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/infdis/jiad293,
title = {Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.},
author = {Chou S and Alain S and Cervera C and Chemaly RF and Kotton CN and Lundgren J and Papanicolaou GA and Pereira MR and Wu JJ and Murray RA and Buss NE and Fournier M},
year = {2024},
journal = {The Journal of infectious diseases},
doi = {10.1093/infdis/jiad293},
url = {https://doi.org/10.1093/infdis/jiad293}
}RIS
TY - JOUR TI - Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients. AU - Chou S AU - Alain S AU - Cervera C AU - Chemaly RF AU - Kotton CN AU - Lundgren J AU - Papanicolaou GA AU - Pereira MR AU - Wu JJ AU - Murray RA AU - Buss NE AU - Fournier M PY - 2024 JO - The Journal of infectious diseases DO - 10.1093/infdis/jiad293 UR - https://doi.org/10.1093/infdis/jiad293 ER -
APA
S, C., S, A., C, C., RF, C., CN, K., J, L., GA, P., MR, P., JJ, W., RA, M., NE, B., & M, F. (2024). Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.. The Journal of infectious diseases. https://doi.org/10.1093/infdis/jiad293
Source records
- pubmed · retrieved 2026-09-26T01:15:54.038Z